Accumulating evidence indicates the significance of FGFR2 in the tumorigenesis and progression of gastric cancer (GC); genomic aberrations in FGFR2 have been linked to one of the most frequently occurring oncogenic aberrations [2, 14–17]. This evidence concerns the gene FGFR2 and gastric cancer.